Price comparison of high-cost originator medicines in European countries-Reference-Cited by-同舟云学术

Price comparison of high-cost originator medicines in European countries

Published:2016-10-11 Issue:2 Volume:17 Page:221-230
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Vogler Sabine¹,Zimmermann Nina¹,Babar Zaheer-Ud-Din²³

Affiliation:

1. WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Health Economics Department, Gesundheit Österreich GmbH (Austrian Public Health Institute), Vienna, Austria

2. Division of Pharmacy Practice, School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand

3. Lahore Pharmacy College (A project of Lahore Medical and Dental College), Tulspura Canal Bank, Lahore 53400, Pakistan

Funder

Austrian Federal Ministry of Health

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2016.1223543

Reference64 articles.

1. Trends and issues in oncology costs

2. Access to orphan drugs in Europe: current and future issues

3. World Health Organization. Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research Geneva, Switzerland: World Health Organization. 2015. [cited 2016 Aug 8] Available from: http://www.euro.who.int/__data/assets/pdf_file/0008/306179/Access-new-medicines-TR-PIO-collaboration-research.pdf?ua=1.

4. Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU. Economic Papers 461, JEL classification: I11, I18. Social Science Electronic Publishing. 2012. [cited 2016 Sep 28] Available from SSRN: http://ssrn.com/abstract=2161803 or http://dx.doi.org/10.2139/ssrn.2161803.

5. Pricing in the Market for Anticancer Drugs

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Speculation, climate or pandemic: Who drives the Chinese herbal medicine bubbles?;China Economic Review;2024-10

2. Medicines prices in International (Geary–Khamis) Dollar. The comparison between regulated and deregulated markets;PLOS ONE;2024-06-07

3. Variables affecting new drug prices in South Korea’s pricing system;Frontiers in Pharmacology;2024-05-09

4. Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs;Pharmacy;2024-03-18

5. European priority review vouchers for neglected disease product development;BMJ Global Health;2024-01